The estimated Net Worth of Richard L Love is at least $1.23 Million dollars as of 28 September 2017. Richard Love owns over 14,600 units of CTI BioPharma Corp stock worth over $670,097 and over the last 17 years Richard sold CTIC stock worth over $559,577.
Richard has made over 12 trades of the CTI BioPharma Corp stock since 2009, according to the Form 4 filled with the SEC. Most recently Richard sold 14,600 units of CTIC stock worth $46,866 on 28 September 2017.
The largest trade Richard's ever made was selling 75,000 units of CTI BioPharma Corp stock on 22 February 2011 worth over $22,500. On average, Richard trades about 9,372 units every 59 days since 2007. As of 28 September 2017 Richard still owns at least 73,718 units of CTI BioPharma Corp stock.
You can see the complete history of Richard Love stock trades at the bottom of the page.
Richard's mailing address filed with the SEC is 501 ELLIOTT AVE W., SUITE 400, SEATTLE, WA, 98119.
Over the last 21 years, insiders at CTI BioPharma Corp have traded over $80,110,449 worth of CTI BioPharma Corp stock and bought 9,566,060 units worth $25,487,533 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., and Advisors Llc Orbi Med Capit.... On average, CTI BioPharma Corp executives and independent directors trade stock every 26 days with the average trade being worth of $1,223,687. The most recent stock trade was executed by Adam R Craig on 24 January 2023, trading 85,317 units of CTIC stock currently worth $71,666.
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
CTI BioPharma Corp executives and other stock owners filed with the SEC include: